Susquehanna Fundamental Investments’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $63.6K | Sell |
36,748
-109,483
| -75% | -$189K | ﹤0.01% | 910 |
|
|
2024
Q1 | $349K | Buy |
+146,231
| New | +$349K | 0.02% | 525 |
|
|
2023
Q4 | – | Sell |
-40,694
| Closed | -$152K | – | 122 |
|
|
2023
Q3 | $152K | Sell |
40,694
-37,054
| -48% | -$139K | 0.01% | 337 |
|
|
2023
Q2 | $332K | Hold |
77,748
| – | – | 0.01% | 500 |
|
|
2023
Q1 | $532K | Sell |
77,748
-5,027
| -6% | -$34.4K | 0.01% | 665 |
|
|
2022
Q4 | $656K | Buy |
+82,775
| New | +$656K | 0.01% | 780 |
|
|
2022
Q1 | – | Sell |
-67,518
| Closed | -$1.08M | – | 1554 |
|
|
2021
Q4 | $1.08M | Buy |
67,518
+14,978
| +29% | +$239K | 0.03% | 620 |
|
|
2021
Q3 | $844K | Sell |
52,540
-33,129
| -39% | -$532K | 0.02% | 942 |
|
|
2021
Q2 | $1.19M | Buy |
85,669
+60,474
| +240% | +$836K | 0.02% | 780 |
|
|
2021
Q1 | $368K | Buy |
+25,195
| New | +$368K | 0.01% | 1239 |
|